FDA
Erythrocin Stearate
The FDA lists this product in 3 strengths and forms.
Composition
- Active ingredients
- ERYTHROMYCIN STEARATE EQ 250MG BASE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- ERYTHROMYCIN STEARATE EQ 500MG BASE · TabletANDA060359-003 · Discontinued
- ERYTHROMYCIN STEARATE EQ 250MG BASE · TabletThis page
- ERYTHROMYCIN STEARATE EQ 125MG BASE · TabletANDA060359-002 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA060359.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Erythrocin Stearate
- Active substance
- erythromycin stearate
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Azurity
- Status
- Discontinued
- FDA approval
- 24 Jun 1964
- Application
- ANDA060359-001